Xiidra (Shire US Manufacturing Inc.)
Welcome to the PulseAid listing for the Xiidra drug offered from Shire US Manufacturing Inc.. This Lymphocyte Function-Associated Antigen-1 Antagonist [EPC],Lymphocyte Function-Associated Antigen-1 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Shire US Manufacturing Inc. |
NON-PROPRIETARY NAME: | Lifitegrast |
SUBSTANCE NAME: | LIFITEGRAST |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC],Lymphocyte Function-Associated Antigen-1 Antagonists [MoA] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-07-11 |
END MARKETING DATE: | 0000-00-00 |
Xiidra HUMAN PRESCRIPTION DRUG Details:
Item Description | Xiidra from Shire US Manufacturing Inc. |
LABELER NAME: | Shire US Manufacturing Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/mL) |
START MARKETING DATE: | 2016-07-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54092-606_b9283437-01b2-4246-bf7a-054bfb3efa1c |
PRODUCT NDC: | 54092-606 |
APPLICATION NUMBER: | NDA208073 |
Other LIFITEGRAST Pharmaceutical Manufacturers / Labelers: